Evidence map›Paper›PMID 29561782›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Optimization of Iron Oxide Tracer Synthesis for Magnetic Particle Imaging.

Sabina Ziemian, Norbert Löwa, Olaf Kosch, Daniel Bajj, Frank Wiekhorst, Gunnar Schütz

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Imaging Constructs: The Rise of Iron Oxide Nanoparticles.Molecules (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabina ZiemianMR and CT Contrast Media Research, Bayer AG, D-13353 Berlin, Germany. sabina.ziemian@bayer.com.ORCID 0000-0002-4910-8173
Norbert LöwaPhysikalisch-Technische Bundesanstalt, D-10587 Berlin, Germany. Norbert.Loewa@ptb.de.ORCID 0000-0001-6245-9042
Olaf KoschPhysikalisch-Technische Bundesanstalt, D-10587 Berlin, Germany. Olaf.Kosch@ptb.de.
Daniel BajjUniversity of British Columbia, Vancouver, BC V6T 1Z3, Canada. daniel.bajj@alumni.ubc.ca.
Frank WiekhorstPhysikalisch-Technische Bundesanstalt, D-10587 Berlin, Germany. Frank.Wiekhorst@ptb.de.
Gunnar SchützMR and CT Contrast Media Research, Bayer AG, D-13353 Berlin, Germany. gunnar.schuetz@bayer.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimization of iron oxide nanoparticles as tracers for magnetic particle imaging (MPI) alongside the development of data acquisition equipment and image reconstruction techniques is crucial for the required improvements in image resolution and sensitivity of MPI scanners. We present a large-scale water-based synthesis of multicore superparamagnetic iron oxide nanoparticles stabilized with dextran (MC-SPIONs). We also demonstrate the preparation of single core superparamagnetic iron oxide nanoparticles in organic media, subsequently coated with a poly(ethylene glycol) gallic acid polymer and phase transferred to water (SC-SPIONs). Our aim was to obtain long-term stable particles in aqueous media with high MPI performance. We found that the amplitude of the third harmonic measured by magnetic particle spectroscopy (MPS) at 10 mT is 2.3- and 5.8-fold higher than Resovist for the MC-SPIONs and SC-SPIONs, respectively, revealing excellent MPI potential as compared to other reported MPI tracer particle preparations. We show that the reconstructed MPI images of phantoms using optimized multicore and specifically single-core particles are superior to that of commercially available Resovist, which we utilize as a reference standard, as predicted by MPS.

Indexed as

iron oxide tracermagnetic particle imaging (MPI)magnetic particle spectroscopy (MPS)superparamagnetic nanoparticles

Identifiers

PMID29561782
PMCPMC5923510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.